Grail Inc banner

Intrinsic Value

The intrinsic value of Grail Inc (NL0) under the Base Case is 30.75 EUR per share. Compared with the current market price of 140.55 EUR, the stock appears Overvalued by 78% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

NL0 Intrinsic Value
€30.75
Overvaluation 78%
Intrinsic Value
Price €140.55

We don’t have enough historical valuation data to make this comparison.

Monitor NL0
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €24.6
Get notified when the price drops into your buy zone
Current Price €140.55
Intrinsic Value €30.75
Margin of Safety 20% €24.6
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to NL0

Fundamental Analysis

What Grail Does

Biotechnology Health Care

Grail is a healthcare diagnostics company that develops blood tests for finding cancer signals early, before symptoms appear. Its best-known product is a multi-cancer early detection test that analyzes fragments of DNA in a blood sample to look for signs of cancer and, in some cases, suggest where in the body the signal may be coming from.

Headquarters
United States of America US
Employees
910
IPO date
Jun 12, 2024
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Grail Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

GRAL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one NL0 stock?

The intrinsic value for Grail Inc (NL0) under the Base Case is 30.75 EUR.

Is NL0 stock undervalued or overvalued?

Compared with the current market price of 140.55 EUR, the stock appears Overvalued by 78% .

Back to Top